Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
23.84
-0.54 (-2.21%)
At close: Mar 24, 2026, 4:00 PM EDT
23.84
0.00 (0.00%)
After-hours: Mar 24, 2026, 4:03 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $4.86 billion as of March 24, 2026. Its market cap has increased by 42.99% in one year.
Market Cap
4.86B
Enterprise Value
3.92B
1-Year Change
42.99%
Ranking
Category
Stock Price
$23.84
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $4.86B, an increase of 3,809.45%. That is a compound annual growth rate of 72.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 4.96B | -3.69% |
| Dec 31, 2025 | 5.15B | 41.70% |
| Dec 31, 2024 | 3.64B | -40.34% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 5.57B |
| PTC Therapeutics | 5.49B |
| CG Oncology | 5.46B |
| Caris Life Sciences | 5.42B |
| Mirum Pharmaceuticals | 5.39B |
| Xenon Pharmaceuticals | 5.23B |
| Scholar Rock Holding | 5.03B |
| Celcuity | 4.99B |